These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

66 related articles for article (PubMed ID: 619830)

  • 1. Hemostatic effects of uniform, low-dose subcutaneous heparin in surgical patients.
    Gurewich V; Nunn T; Kuriakose TT; Hume M
    Arch Intern Med; 1978 Jan; 138(1):41-4. PubMed ID: 619830
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Activated coagulation time in monitoring heparinized dogs.
    Green RA
    Am J Vet Res; 1980 Nov; 41(11):1793-7. PubMed ID: 7212408
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Complications of low-dose heparin prophylaxis in gynecologic oncology surgery.
    Clarke-Pearson DL; DeLong ER; Synan IS; Creasman WT
    Obstet Gynecol; 1984 Nov; 64(5):689-94. PubMed ID: 6493660
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Informative value of control methods for postoperative supervision of medication with aspirin and heparin (author's transl)].
    Schöndorf TH; Hey D
    MMW Munch Med Wochenschr; 1977 Jan; 119(4):119-22. PubMed ID: 402555
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Are activated clotting times helpful in the management of anticoagulation with subcutaneous low-molecular-weight heparin?
    Henry TD; Satran D; Knox LL; Iacarella CL; Laxson DD; Antman EM
    Am Heart J; 2001 Oct; 142(4):590-3. PubMed ID: 11579347
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bleeding and thrombosis in high-risk renal transplantation candidates using heparin.
    Mathis AS; Davé N; Shah NK; Friedman GS
    Ann Pharmacother; 2004 Apr; 38(4):537-43. PubMed ID: 14766999
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Complications and risks associated with an anticoagulation therapy combining low molecular weight heparin and Warfarin after total replacement of large joints--our experience].
    Míka P; Behounek J; Skoták M; Nevsímal L
    Acta Chir Orthop Traumatol Cech; 2004; 71(4):237-44. PubMed ID: 15456102
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Effect of low-dosage intravenous nitrate therapy on the anticoagulant effect of heparin].
    Bechtold H; Kleist P; Landgraf K; Möser K
    Med Klin (Munich); 1994 Jul; 89(7):360-6. PubMed ID: 7935224
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Perioperative monitoring of primary and secondary hemostasis in coronary artery bypass grafting.
    Hertfelder HJ; Bös M; Weber D; Winkler K; Hanfland P; Preusse CJ
    Semin Thromb Hemost; 2005; 31(4):426-40. PubMed ID: 16149021
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of sodium heparin and antithrombin III concentration on activated partial thromboplastin time in the dog.
    Hellebrekers LJ; Slappendel RJ; van den Brom WE
    Am J Vet Res; 1985 Jul; 46(7):1460-2. PubMed ID: 4026027
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevention of venous thromboembolism in surgical patients by low-dose heparin: prepared by the Council on Thrombosis of the American Heart Association.
    Circulation; 1977 Feb; 55(2):423-426A. PubMed ID: 832357
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The abdomen, thigh, and arm as sites for subcutaneous sodium heparin injections.
    Fahs PS; Kinney MR
    Nurs Res; 1991; 40(4):204-7. PubMed ID: 1857645
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevention of postoperative deep vein thrombosis by two different heparin types.
    Catania G; Salanitri G
    Int J Clin Pharmacol Ther Toxicol; 1988 Jun; 26(6):304-9. PubMed ID: 2842266
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Plasma heparin values and hemostasis in equids after subcutaneous administration of low-dose calcium heparin.
    Gerhards H; Eberhardt C
    Am J Vet Res; 1988 Jan; 49(1):13-8. PubMed ID: 3354959
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Subcutaneous adjusted-dose unfractionated heparin vs fixed-dose low-molecular-weight heparin in the initial treatment of venous thromboembolism.
    Prandoni P; Carnovali M; Marchiori A;
    Arch Intern Med; 2004 May; 164(10):1077-83. PubMed ID: 15159264
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Biological activity and safety of the subcutaneous administration of high doses of low molecular weight heparin for 8 days in human volunteers.
    Harenberg J; Giese C; Dempfle CE; Stehle G; Heene DL
    Thromb Haemost; 1989 Jun; 61(3):357-62. PubMed ID: 2552604
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Heparin resistance and increased platelet activation in coronary surgery patients treated with enoxaparin preoperatively.
    Pleym H; Videm V; Wahba A; Asberg A; Amundsen T; Bjella L; Dale O; Stenseth R
    Eur J Cardiothorac Surg; 2006 Jun; 29(6):933-40. PubMed ID: 16675258
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Prevention of postoperative thrombo-embolic accidents following thoracic surgery by low-dose calcium heparinate: a comparative study (author's transl)].
    Le Brigand H; Morille P; Garnier B; Bogaty-Yver J; Samama M; Spriet A
    Sem Hop; 1981 May 18-25; 57(19-20):972-7. PubMed ID: 6266028
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Different effects of heparin in males and females.
    Campbell NR; Hull RD; Brant R; Hogan DB; Pineo GF; Raskob GE
    Clin Invest Med; 1998 Apr; 21(2):71-8. PubMed ID: 9562927
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Activated coagulation and activated partial thromboplastin times in assessment and reversal of heparin-induced anticoagulation for cardiopulmonary bypass.
    Dauchot PJ; Berzina-Moettus L; Rabinovitch A; Ankeney JL
    Anesth Analg; 1983 Aug; 62(8):710-9. PubMed ID: 6869857
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.